Gelonghui March 25 丨 Changchun Hi-Tech (000661.SZ) held a performance briefing on March 25, 2024. Regarding “What is the current sales share of long-lasting growth hormone?” The company replied that in 2023, the company's share of growth hormone product revenue for long-acting water injections had increased to about 29%.
长春高新(000661.SZ):2023年度公司长效水针在生长激素产品收入占比已提升到29%左右
Changchun Hi-Tech (000661.SZ): The share of the company's long-term water needles in growth hormone product revenue has increased to about 29% in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.